Perjeta regimen helped people with HER2-positive early breast cancer live longer without their disease returning or getting worse compared to Herceptin and chemotherapy

… (pre-surgery) treatment of HER2-positive early breast cancer (eBC) * These data suggest that … adjuvant treatment of HER2-positive early breast cancer." The results also suggest … treatment of HER2-positive breast cancer: Herceptin, Perjeta and Kadcyla. HER2-positive breast cancer is a …